Helogen builds autonomous orbital platforms for biomanufacturing and biological research. Its HEL-IOS system combines bioreactors, onboard analytics, and spacecraft to enable remote microgravity experiments and the production of biomaterials for medical uses such as implants and regenerative therapies. The company stands out through an end-to-end, integrated orbital biomanufacturing platform and active partnerships with LambdaVision and Starlab Space, plus a NASA TechLeap collaboration that gives access to orbital environments. Its goal is to enable practical, regulatory-aligned space biomanufacturing by delivering repeatable, data-rich processes on orbit.
Company Size
11-50
Company Stage
Seed
Total Funding
$7.9M
Headquarters
New York City, New York
Founded
2022
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?